SOMRS
CRSP icon

State of Michigan Retirement System’s CRISPR Therapeutics CRSP Stock Holding History

State of Michigan Retirement System’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-32,386
Closed -$3.63M – 980
2021
Q3 		$3.63M Hold
32,386
– – 0.02% 468
2021
Q2 		$5.24M Hold
32,386
– – 0.03% 397
2021
Q1 		$3.95M Hold
32,386
– – 0.03% 468
2020
Q4 		$4.96M Sell
32,386
-11,010
-25% -$1.3M 0.03% 371
2020
Q3 		$3.63M Buy
+43,396
New +$3.85M 0.03% 404

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

State of Michigan Retirement System's CRSP Position: Q4 2021 in Review

State of Michigan Retirement System sold out of CRISPR Therapeutics (CRSP) in Q4 2021, closing a stake of 32,386 shares — an estimated $3.63M sold.

State of Michigan Retirement System first reported a position in CRSP in Q3 2020 and held it in 5 quarters. The position peaked at $5.24M in Q2 2021. 446 funds tracked by Wall St. Rank hold CRSP as of Q4 2021.

  • State of Michigan Retirement System reported no remaining CRISPR Therapeutics position as of Q4 2021 after selling out during the quarter.
  • State of Michigan Retirement System sold 32,386 CRISPR Therapeutics shares in Q4 2021, an estimated $3.63M.
  • State of Michigan Retirement System first reported a position in CRISPR Therapeutics in Q3 2020 and held it in 5 quarters.
  • State of Michigan Retirement System's CRISPR Therapeutics position peaked at $5.24M in Q2 2021.
  • 446 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q4 2021.

Based on State of Michigan Retirement System's 13F filing for Q4 2021, filed 27 Jan 2022.